Origin Life Sciences Downsizes IPO
By Will Feuer Origin Life Sciences, a biotechnology company, downsized its planned initial public offering. The company now plans to offer 1.875 million...
Source: marketwatch.com
Stay updated with breaking news from Origin Life Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
By Will Feuer Origin Life Sciences, a biotechnology company, downsized its planned initial public offering. The company now plans to offer 1.875 million...
Novel Therapeutic Technology Developed & Manufactured by ADM Tronics ...